Hospital pharmacists are increasingly playing a critical role in the care\nof patients with multiple sclerosis (MS). However, little is known about their preferences and\nperspectives towards different attributes of disease-modifying therapies (DMTs). The objective of this\nresearch was to assess pharmacists´ preferences for DMT efficacy attributes. Methods: A multicenter,\nnon-interventional, cross-sectional, web-based study was conducted. Preventing relapses, delaying\ndisease progression, controlling radiological activity, and preserving health-related quality of life\n(HRQoL) and cognition were the attributes selected based on a literature review and a focus group with\nsix hospital pharmacists. Conjoint analysis was used to determine preferences in eight hypothetical\ntreatment scenarios, combining different levels of each attribute and ranking them from most to least\npreferred. Results: Sixty-five hospital pharmacists completed the study.........................
Loading....